Please provide your email address to receive an email when new articles are posted on . The FDA has granted 510(k) clearance to a plant-based, hemostatic gel to treat moderate to severe bleeding, ...

NEW YORK, July 9, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced the successful completion ...

Please provide your email address to receive an email when new articles are posted on . A Brooklyn-based biotech firm has announced successful completion of the first phase of a preclinical study ...

COLLEGE PARK, Md., Sept. 25, 2024 /PRNewswire/ -- Medcura, Inc., a leader in innovative hemostasis solutions that deploy patented biopolymer technologies to control surgical bleeding, is pleased to ...

NEW YORK, April 8, 2021 /PRNewswire/ — Cresilon, Inc., the Brooklyn-based biotechnology company, announced today the successful close of its Series A-3 financing, totaling $38.5 million. This ...

The last time a college student founded a healthcare startup promising to do something revolutionary with blood, it ended up being quite messy. Hopefully things go better for Cresilon. The ...

NEW YORK, June 11, 2024 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into a ...

VETIGEL, a revolutionary plant-based hemostatic gel that instantly stops and controls bleeding, is now available for veterinarian surgeons across Canada through McCarthy Vet. The agreement with ...

In emergencies, controlling the blood loss from a wound can be critical. Joe Landolina of Cresilon shares the progress being made with hemostatic gel that can stop the bleeding in seconds rather than ...

Pune, Maharashtra, December 17 2020 (Wiredrelease) Market.Biz –:Businesses must navigate the financial and operational challenges of coronavirus while rapidly addressing the needs of their people, ...